iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.8000
+0.0086 (1.09%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2019
Period Ending
Jun '24 Jun '22 Jun '21 Jun '20 Jun '19 2017 - 2019
Precision Antibodies
225.00K
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals (iBio Inc.)
-
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceuticals (iBio Inc.) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Bioprocessing (iBio CDMO)
-
Log In
Log In
Log In
Log In
Upgrade
Bioprocessing (iBio CDMO) Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is July - June.
Fiscal Year
FY 2024 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2019
Period Ending
Jun '24 Jun '22 Jun '21 Jun '20 Jun '19 2017 - 2019
United States
225.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-90.56%
Log In
Log In
Log In
Log In
Upgrade